GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 101 filers reported holding GRITSTONE ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,298,948 | -29.9% | 666,127 | 0.0% | 0.10% | -31.4% |
| Q1 2023 | $1,851,833 | -19.4% | 666,127 | 0.0% | 0.15% | -21.9% |
| Q4 2022 | $2,298,138 | -61.6% | 666,127 | -71.4% | 0.20% | -58.6% |
| Q3 2022 | $5,989,000 | +6.2% | 2,330,504 | 0.0% | 0.47% | -3.7% |
| Q2 2022 | $5,640,000 | -41.3% | 2,330,504 | 0.0% | 0.49% | -33.7% |
| Q1 2022 | $9,602,000 | -68.3% | 2,330,504 | -1.1% | 0.74% | -61.7% |
| Q4 2021 | $30,302,000 | +19.1% | 2,356,282 | 0.0% | 1.94% | +26.1% |
| Q3 2021 | $25,448,000 | +18.3% | 2,356,282 | 0.0% | 1.54% | +29.5% |
| Q2 2021 | $21,513,000 | -0.7% | 2,356,282 | +2.5% | 1.19% | -4.0% |
| Q1 2021 | $21,674,000 | – | 2,298,382 | – | 1.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,561,150 | $6,125,178 | 3.26% |
| Redmile Group, LLC | 8,509,126 | $14,635,697 | 0.70% |
| Avidity Partners Management LP | 2,733,800 | $4,702,136 | 0.19% |
| Frazier Life Sciences Management, L.P. | 1,430,878 | $2,461,110 | 0.16% |
| Artia Global Partners LP | 95,170 | $163,692 | 0.07% |
| Worth Venture Partners, LLC | 43,772 | $75,288 | 0.04% |
| SkyOak Wealth, LLC | 60,875 | $104,705 | 0.03% |
| Point72 Asset Management, L.P. | 5,924,867 | $10,190,771 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 76,811 | $132,115 | 0.02% |
| Houlihan Financial Resource Group, Ltd. | 20,000 | $38 | 0.02% |